ECP 2019 Final Programme

Sunday, 8 Sept 82 ECP 2019 · Nice Poster Sessions a Sunday PS-01 040 Prevalence of incidental atypical proliferation lesions in reduction mammoplasty speci- mens: a 6-year retrospective analysis at a tertiary breast unit Jasmin Lee, United Kingdom F. Rashid, R. Ramakrishnan, K. Lessey, S. Shousha 041 Prognostic value of CEACAM1 in breast cancer in situ Mykola Lyndin, Ukraine R. Moskalenko, A. Romaniuk, B. B. Singer 042 HER2 status in breast cancer: immunohis- tochemistry and gene amplification in the Republic of Kazakhstan Svetlana Lyubko, Kazakhstan E. Satbaeva 043 Metaplastic carcinoma of the breast, about a series of 15 cases Zakaria Merad, Algeria 044 Biopathological significance of deregulated PIWIL1-4 proteins belonging to the PIWI- piRNA pathway in invasive breast carcinomas Didier Meseure, France M. Lae, K. Drak Alsibai, A. Nicolas, S. Vacher, W. Chemlali, Y. Allory, A. Vincent-Salomon, I. Bieche 045 Loss of GATA3 associates with aggressive breast cancer, a basal like phenotype, and immune cell activation Anna Kristine Myrmel Sæle, Norway A. A. Svanøe, C. Askeland, G. Knutsvik, B. Davidsen, T. Aas, K. Collett, I. M. Stefansson, L. A. Akslen, E. Wik 046 Fascin-1 expression in breast cancer identifies patients with high risk for disease recurrence Aphrodite Nonni, Greece E. C. Tampaki, A. Tampakis, P. Efstratios, K. Kontzoglou, G. Kouraklis 033 Pathological predictors of axillary node involvement in breast cancer patients Vlada Kometova, Russia Y. Dergunova, V. Bojenko, M. Dardyk, M. Rodionova, V. Rodionov 034 Changes of oestrogen receptor, progester- one receptor and Her2 / neu statuses of local metastases compared with primary tumour in breast cancer Konstantin Konyshev, Russia S. Sazonov 035 Breast implant associated anaplastic large cell lymphoma (BIA-ALCL) – case report and review of the literature Anikó Kovács, Sweden U. Hansson, S. Bram Ednersson, B. Márton, K. Helou, T. Parris, S. Janeva 036 Comparison of immunohistochemically assessed ER, PGR, HER2, and Ki-67 breast cancer biomarker status with the automated STRAT4 RT-qPCR-based diagnostic platform – a retrospective study on 100 breast carcinomas (core biopsies and matching surgical specimens) Anikó Kovács, Sweden T. Parris, S. De Lara, S. Nasic, S. Janeva 038 PD-L1 status in triple negative and luminal B HER2-negative breast carcinomas after neoadjuvant therapy Olga Kuznetsova, Russia G. Frank, L. Zavalishina, Y. Andreeva, M. Shomova, M. Vinogradov 039 Association between clinicopathological markers and survival in hormone receptor-positive breast carcinoma treated with neoadjuvant chemotherapy Ho-chang Lee, Republic of Korea W. Han, S. Im, T. Kim, K. Lee, I. A. Park